ImageneBio Inc
39 hedge funds and large institutions have $272M invested in ImageneBio Inc in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 20 increasing their positions, 8 reducing their positions, and 5 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 8
0.04% less ownership
Funds ownership: 4.9% → 4.85% (-0.04%)
7% less funds holding
Funds holding: 42 → 39 (-3)
7% less capital invested
Capital invested by funds: $293M → $272M (-$21.3M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.26M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.54M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$935K |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$783K |
| 5 |
State Street
Boston,
Massachusetts
|
+$678K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
CHI Advisors
New York
|
-$6.05M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$4.91M |
| 3 |
OCA
Octagon Capital Advisors
New York
|
-$1.51M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.4M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$1.25M |
IMA Hedge Fund Activity: Q3 2021 in Review
39 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q3 2021, worth a combined $272M — down 7.3% from $293M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of IMA and 2 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 20 added.
The largest buyer was Fidelity Investments, adding an estimated $7.26M. The largest seller was CHI Advisors, cutting an estimated $6.05M.
- 39 institutional investors held ImageneBio Inc (IMA) as of Q3 2021, down from 42 in Q2 2021.
- Funds reported $272M of ImageneBio Inc stock for Q3 2021, down 7.3% quarter-over-quarter.
- 2 funds opened new ImageneBio Inc positions in Q3 2021 and 5 closed out, a net change of -3 holders.
- The largest ImageneBio Inc buyer in Q3 2021 was Fidelity Investments, an estimated $7.26M added.
- The largest ImageneBio Inc seller in Q3 2021 was CHI Advisors, an estimated $6.05M sold.
Based on aggregated 13F filings for Q3 2021.